Protalix BioTherapeutics announced that its CFO, Gilad Mamlok, will participate in two key investor events in New York City from September 14-16, 2026. He will present at the H.C. Wainwright 28th Annual Global Investment Conference and join a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. These appearances highlight Protalix's ongoing efforts to engage investors as it advances its rare disease therapies, including enzyme replacement treatments and drugs in development. Live and archived webcasts will be available for investors unable to attend in person.
Natural Grocers, the largest family-run organic retailer in the U.S., is celebrating Organic Month with special savings for its {N}power members throughout September. From September 17 to 19, customers can enjoy exclusive offers, participate in educa...
Aurania Resources has begun a drilling program at the Thor's Valley gold project in Iceland, aiming to drill six holes totaling about 770 meters. The project has a history of high-grade gold mineralization, with previous drilling returning grades up ...
JP Morgan has maintained an 'overweight' rating on European banks, highlighting a favorable environment for growth despite early signs of interest rate changes. The sector benefits from ECB rates between 2% and 3%, strong lending momentum partly driv...
North Peak Resources has begun diamond drilling at its Prospect Mountain Mine Complex in Nevada to investigate refined magnetotelluric geophysical anomalies, focusing on a main sulphide target. Previous drilling in 2023 found high-grade zinc and silv...
Quimbaya Gold Inc. completed six drill holes totaling 2,927.9 meters at its Tahami Center project in Colombia, confirming the presence of a copper-molybdenum porphyry system as predicted by their exploration model. The drilling revealed potassic alte...
